Video Posters | RheumNow

Poster Hall

Eular Poster Abbvie

Safety Profile of a JAKi in Patients with Rheumatoid Arthritis With up to 6.5 Years of Exposure

Save

Sponsored by AbbVie Medical Affairs

Sep 21, 2023

Abbvie ACR Poster

Safety and Efficacy of a JAKi in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biologic DMARDs: Results Through 5 Years From the SELECT-BEYOND Study

Save

Sponsored by AbbVie Medical Affairs

Sep 21, 2023

More Virtual Posters

Sponsored by Bristol Myers Squibb

Design of 2 phase 3, double-blind, placebo-controlled, global trials of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with active systemic lupus erythematosus

Bimekizumab Poster

Sponsored by UCB

Bimekizumab Maintains Improvements in Efficacy Endpoints and has a Consistent Safety Profile Through 52 Weeks in Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Results from Two Parallel Phase 3 Studies

Glucocorticoid Poster

Sponsored by Sanofi

Glucocorticoid (GC)-free resolution of polymyalgia rheumatica (PMR) signs and symptoms in patients treated with sarilumab with history of flare: analysis from SAPHYR

Sponsored by Sanofi

Patient reported outcomes from a Randomized Controlled Phase 3 Trial of Sarilumab in Polymyalgia Rheumatica

Sponsored by Sanofi

Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)

×